Literature DB >> 20372060

The interaction of p53 with 3'-terminal mismatched DNA.

Mary Bakhanashvili1, Amnon Hizi, Galia Rahav.   

Abstract

The diversity of p53 functions involves its interaction with sequence-specific, non-sequence-specific and various damaged sites in DNA. The preferential excision of misincorporated over correct nucleotides by the 3'→5' exonuclease activity of p53 provides a molecular basis for p53 involvement in the correction of the DNA replication errors. However, p53 exhibits variations in its comparative efficiency to excise different 3'-terminal mismatched nucleotides. To determine the importance of the binding capacity of the protein to various 3'-terminal damaged sites, we have examined the interaction of p53 with linear dsDNAs containing various 3'-terminal mismatches, employing a gel retardation assay. The data demonstrate the intrinsic 3'-terminal mismatched DNA binding capacity of p53. Since p53 binds directly to various 3'-terminal purine:pyrimidine and purine:purine mispairs to an equal extent, p53 can be considered as a general 3'-mismatched DNA binding protein. Apparently, 3'-terminal mismatched bases are structural element to which p53 can bind, that extends the spectrum of damage sites to which p53 may respond. The formation of the p53-mismatched DNA complex is independent of the sequence context. Thus, the dissimilarities in mispair excision efficiency are probably due to an inherent property of the p53 in excision of 3'-mismatched nucleotides by a bound protein. The results establish a framework for understanding the mechanism of cooperative interaction between p53 and exonuclease-deficient DNA polymerase (e.g. HIV-1 RT). Within the context of error-correction events, p53 by recognition and excision of 3'-mismatched nucleotides from DNA, may be involved in DNA repair, thus increasing the accuracy of DNA synthesis by DNA polymerases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372060     DOI: 10.4161/cc.9.7.11201

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  4 in total

1.  DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression.

Authors:  Stephanie Hampp; Tina Kiessling; Kerstin Buechle; Sabrina F Mansilla; Jürgen Thomale; Melanie Rall; Jinwoo Ahn; Helmut Pospiech; Vanesa Gottifredi; Lisa Wiesmüller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-12       Impact factor: 11.205

2.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells.

Authors:  Krassimira Botcheva; Sean R McCorkle; W R McCombie; John J Dunn; Carl W Anderson
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

3.  p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA.

Authors:  Elad Bonda; Galia Rahav; Angelina Kaya; Mary Bakhanashvili
Journal:  Oncotarget       Date:  2016-11-08

4.  Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Authors:  Jackson R Taylor; Brian D Lehmann; William H Chappell; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2011-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.